The purpose of this study is to evaluate if the drug, Pasireotide, is safe and effective in
reducing the gastrointestinal side effects of the drugs received to prepare for allogeneic
stem cell transplant. The study will also evaluate if Pasireotide is effective in reducing
acute and chronic Graft-versus-Host-Disease (GvHD) after transplant.